AU2011231645A1 - Fast dissolving drug delivery systems - Google Patents

Fast dissolving drug delivery systems Download PDF

Info

Publication number: AU2011231645A1
Authority: AU; Australia
Prior art keywords: fast dissolving; oral; film according; dissolving film; difficulties
Prior art date: 2010-03-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2011231645A

Other languages

English (en)

Other versions

AU2011231645A2 (en

Inventor

Dominique Costantini

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

APR Applied Pharma Research SA

Original Assignee

Bioalliance Pharma SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-03-23

Filing date

2011-03-23

Publication date

2012-10-18

2010-03-23 Priority claimed from EP10305288A external-priority patent/EP2377526A1/fr

2010-03-23 Priority claimed from US12/729,735 external-priority patent/US20110237563A1/en

2011-03-23 Application filed by Bioalliance Pharma SA filed Critical Bioalliance Pharma SA

2012-10-18 Publication of AU2011231645A1 publication Critical patent/AU2011231645A1/en

2012-12-20 Publication of AU2011231645A2 publication Critical patent/AU2011231645A2/en

2013-08-15 Assigned to APR APPLIED PHARMA RESEARCH, S.A. reassignment APR APPLIED PHARMA RESEARCH, S.A. Request for Assignment Assignors: BIOALLIANCE PHARMA

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Hospice & Palliative Care (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2011231645A 2010-03-23 2011-03-23 Fast dissolving drug delivery systems Abandoned AU2011231645A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
EP10305288A EP2377526A1 (fr)	2010-03-23	2010-03-23	Systèmes d'administration de médicaments à dissolution rapide
US12/729,735 US20110237563A1 (en)	2010-03-23	2010-03-23	Fast dissolving drug delivery systems
EP10305288.2		2010-03-23
US12/729,735		2010-03-23
PCT/EP2011/054482 WO2011117313A1 (fr)	2010-03-23	2011-03-23	Systèmes d'administration de médicaments à dissolution rapide

Publications (2)

Publication Number	Publication Date
AU2011231645A1 true AU2011231645A1 (en)	2012-10-18
AU2011231645A2 AU2011231645A2 (en)	2012-12-20

Family

ID=44070534

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2011231645A Abandoned AU2011231645A1 (en)	2010-03-23	2011-03-23	Fast dissolving drug delivery systems

Country Status (9)

Country	Link
EP (1)	EP2549988A1 (fr)
KR (1)	KR20130012067A (fr)
CN (1)	CN103025321A (fr)
AU (1)	AU2011231645A1 (fr)
BR (1)	BR112012024092A2 (fr)
CA (1)	CA2794042A1 (fr)
RU (1)	RU2560693C2 (fr)
WO (1)	WO2011117313A1 (fr)
ZA (1)	ZA201207900B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3254676B1 (fr)	2009-10-30	2018-11-28	IX Biopharma Ltd	Forme de dosage solide à dissolution rapide
US12186426B2 (en)	2009-10-30	2025-01-07	Ix Biopharma Ltd.	Solid dosage form
CN102920683B (zh) *	2012-06-11	2013-08-14	江苏豪森药业股份有限公司	奥氮平口腔速溶膜
CN102860997A (zh) *	2012-09-28	2013-01-09	天津市聚星康华医药科技有限公司	一种遮味的昂丹司琼口腔速溶膜及其制备方法
CN102846581A (zh) *	2012-09-28	2013-01-02	天津市聚星康华医药科技有限公司	一种盐酸氨溴索口腔速溶膜及其制备方法
CA2886573C (fr) *	2012-10-11	2019-04-02	Stephen Lim Chin Beng	Forme de dosage solide
CN103432105A (zh) *	2013-09-02	2013-12-11	天津市聚星康华医药科技有限公司	一种美克洛嗪口腔用膜剂及其制备方法
CN104666280B (zh) *	2015-03-21	2017-10-13	合肥华方医药科技有限公司	一种格列吡嗪口腔速溶膜及其制备方法
CN104958279A (zh) *	2015-06-27	2015-10-07	万特制药(海南)有限公司	氯雷他定口腔速溶膜及其制备方法
CN104940174A (zh) *	2015-07-23	2015-09-30	合肥华方医药科技有限公司	一种盐酸多奈哌齐口腔速溶膜剂的制备方法
DE102017112527B4 (de) *	2017-06-07	2019-01-03	Lts Lohmann Therapie-Systeme Ag	Schnell zerfallende Schaumwafer mit hohem Flächengewicht
JP7710850B2 (ja)	2017-12-29	2025-07-22	ラクソンメディカルアーゲー	薬物送達システム
CN108078962A (zh) *	2018-01-29	2018-05-29	中国药科大学	一种盐酸多奈哌齐口腔速溶膜剂及其制备方法
CN108142940B (zh) *	2018-02-05	2021-05-14	中山大学附属第三医院（中山大学肝脏病医院）	一种促吞咽软片及其制备方法
CA3106579A1 (fr) *	2018-07-15	2020-01-23	Rapid Dose Therapeutics Corp.	Bande de film cannabinoide dispersible par voie orale
CN113613862A (zh)	2019-01-31	2021-11-05	日精Asb机械株式会社	树脂容器的生产装置和生产方法
KR20210111848A (ko)	2019-01-31	2021-09-13	닛세이 에이. 에스. 비 기카이 가부시키가이샤	프리폼의 온도조정장치 및 온도조정방법 및 수지성형 용기의 제조장치 및 제조방법
CN113613861B (zh)	2019-01-31	2024-06-14	日精Asb机械株式会社	用于生产树脂容器的装置和方法
EP3919253A4 (fr)	2019-01-31	2023-01-04	Nissei Asb Machine Co., Ltd.	Appareil de fabrication de récipient en résine, dispositif de réglage de température, procédé de fabrication de récipient en résine et procédé de réglage de température
US11179331B1 (en)	2020-04-21	2021-11-23	Cure Pharmaceutcai Holding Corp	Oral soluble film containing sildenafil citrate

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0717761A4 (fr)	1993-08-19	1998-01-07	Cygnus Therapeutic Systems	Auto-adhesif soluble dans l'eau adherant a une muqueuse et dispositifs servant a le positionner dans une cavite corporelle revetue d'une muqueuse
US5800832A (en)	1996-10-18	1998-09-01	Virotex Corporation	Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
WO2003063927A2 (fr) *	2001-11-16	2003-08-07	Eisai Co. Ltd	Compositions et procedes permettant de traiter les troubles gastro-intestinaux
US6750291B2 (en)	2002-04-12	2004-06-15	Pacific Corporation	Film-forming agent for drug delivery and preparation for percutaneous administration containing the same
WO2003093260A1 (fr)	2002-04-30	2003-11-13	Biogal Gyogyszergyar Rt.	Nouvelles formes cristallines d'ondansetron, procedes de preparation correspondant, compositions pharmaceutiques contenant ces nouvelles formes et procedes de traitement de la nausee au moyen des ces nouvelles formes
WO2005009386A2 (fr) *	2003-07-24	2005-02-03	Smithkline Beecham Corporation	Films a dissolution orale
ES2238001B1 (es)	2004-01-21	2006-11-01	Vita Cientifica, S.L.	Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos.
KR100789227B1 (ko) *	2004-02-23	2008-01-02	유로-셀띠끄 소시에떼 아노님	남용 방지 오피오이드 경피 전달 장치
DE102005033942A1 (de) *	2005-07-20	2007-02-22	Hexal Ag	Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für Antiemetikum oder Antimigränemittel
FR2905268B1 (fr)	2006-09-01	2009-01-23	Unither Dev Soc Par Actions Si	Substitut salivaire
WO2008040534A2 (fr)	2006-10-02	2008-04-10	LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH	Formes pharmaceutiques à base de film non muco-adhésif
US20100215774A1 (en) *	2007-02-09	2010-08-26	Todd Maibach	Film comprising nitroglycerin
WO2008140460A1 (fr) *	2007-05-16	2008-11-20	Fmc Corporation	Forme solide
US20090004254A1 (en) *	2007-06-19	2009-01-01	Todd Maibach	Film comprising active drugs
US20090047330A1 (en) *	2007-08-17	2009-02-19	Ramesh Bangalore	Oral fast dissolving films for erectile dysfunction bioactive agents
US20090047350A1 (en) *	2007-08-17	2009-02-19	Ramesh Bangalore	Perforated water soluble polymer based edible films
WO2009043588A2 (fr) *	2007-10-02	2009-04-09	LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH	Films antibactériens de régulation de ph pour la cavité buccale ou vaginale

2011
- 2011-03-23 AU AU2011231645A patent/AU2011231645A1/en not_active Abandoned
- 2011-03-23 KR KR1020127026904A patent/KR20130012067A/ko not_active Withdrawn
- 2011-03-23 CA CA2794042A patent/CA2794042A1/fr not_active Abandoned
- 2011-03-23 WO PCT/EP2011/054482 patent/WO2011117313A1/fr not_active Ceased
- 2011-03-23 EP EP11709445A patent/EP2549988A1/fr not_active Withdrawn
- 2011-03-23 BR BR112012024092A patent/BR112012024092A2/pt not_active IP Right Cessation
- 2011-03-23 RU RU2012144848/15A patent/RU2560693C2/ru active
- 2011-03-23 CN CN2011800230084A patent/CN103025321A/zh active Pending
2012
- 2012-10-19 ZA ZA2012/07900A patent/ZA201207900B/en unknown

Also Published As

Publication number	Publication date
CN103025321A (zh)	2013-04-03
RU2560693C2 (ru)	2015-08-20
WO2011117313A1 (fr)	2011-09-29
BR112012024092A2 (pt)	2016-09-06
AU2011231645A2 (en)	2012-12-20
ZA201207900B (en)	2013-06-26
CA2794042A1 (fr)	2011-09-29
KR20130012067A (ko)	2013-01-31
RU2012144848A (ru)	2014-04-27
EP2549988A1 (fr)	2013-01-30

Publication	Publication Date	Title
AU2011231645A1 (en)	2012-10-18	Fast dissolving drug delivery systems
US20110237563A1 (en)	2011-09-29	Fast dissolving drug delivery systems
US20240108615A1 (en)	2024-04-04	Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US9655843B2 (en)	2017-05-23	Transmucosal delivery devices with enhanced uptake
KR20110097801A (ko)	2011-08-31	구강 삽입용 투여 제형
EP2377526A1 (fr)	2011-10-19	Systèmes d'administration de médicaments à dissolution rapide
JP2010100550A (ja)	2010-05-06	医薬組成物
NZ622610B2 (en)	2016-08-30	Abuse-resistant mucoadhesive devices for delivery of buprenorphine
HK1198958B (en)	2018-08-03	Abuse-resistant mucoadhesive devices for delivery of buprenorphine

Legal Events

Date	Code	Title	Description
2012-12-20	DA3	Amendments made section 104	Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 26 NOV 2012
2013-08-15	PC1	Assignment before grant (sect. 113)	Owner name: APR APPLIED PHARMA RESEARCH, S.A. Free format text: FORMER APPLICANT(S): BIOALLIANCE PHARMA
2015-10-22	MK4	Application lapsed section 142(2)(d) - no continuation fee paid for the application

Date

Code

Title

Description

2012-12-20

DA3

Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 26 NOV 2012

2013-08-15

PC1

Assignment before grant (sect. 113)

Owner name: APR APPLIED PHARMA RESEARCH, S.A.

Free format text: FORMER APPLICANT(S): BIOALLIANCE PHARMA

2015-10-22

MK4

Application lapsed section 142(2)(d) - no continuation fee paid for the application